Back to search
FDAFDA · Food and drugs·Recall number D-0155-2018

Gabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: Solco Healthcare US, LLC, Cranbury, NJ, 08512, USA. NDC 43547-0333-50

Published January 17, 2018 · Recall initiated: December 4, 2017

Summary

FDA records drug Class II recall D-0155-2018, published January 17, 2018 and initiated December 4, 2017. Recalling firm: Solco Healtcare US LLC; Status: Terminated; Reported quantity: N/A; Lot: Lot # 7700656A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Solco Healtcare US LLC
Distributor
Product was distributed in Mason, OH.
Lot
Lot # 7700656A
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: Solco Healthcare US, LLC, Cranbury, NJ, 08512, USA. NDC 43547-0333-50 recalled?

Yes. FDA published recall D-0155-2018 on January 17, 2018. Reported hazard: Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg

What should I do if I have this product?

Voluntary: Firm initiated · Letter